VANGUARD GROUP INC 13D and 13G filings for Tonix Pharmaceuticals Holding Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 1:32 pm Sale | 2026-03-13 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | VANGUARD GROUP INC | 0 0.000% | -673,605 (Position Closed) | Filing |
| 2026-01-30 2:45 pm Purchase | 2025-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | VANGUARD GROUP INC | 673,605 5.020% | 116,648 (+20.94%) | Filing |
| 2025-10-31 11:31 am Purchase | 2025-09-30 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | VANGUARD GROUP INC | 556,957 6.350% | 556,957 (New Position) | Filing |